Published • loading... • Updated
How Novartis Fights Alzheimer's and Parkinson's (B+)
Summary by blick.ch
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The Basel-based pharmaceutical giant Novartis bought the US biotech company Avidity for $12 billion. The acquisition was about rare neuromuscular diseases. But that's only half the story.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
